CRH Medical renews normal course issuer bid — 3 insights

The Toronto Stock Exchange approved CRH Medical’s intention to renew its normal course issuer bid.

Advertisement

Here’s what you should know:

1. CRH may purchase up to 7 million of its common shares, representing 9.74 percent of its outstanding common shares.

2. CRH currently has 72.3 million in common shares and a public float of 70.44 million.

3. CRH will fund the bid with generated cash flow.

More articles on healthcare: 
3 thoughts on managing denials from employer plans
GI societies slam CMS decision to side with Anthem, devalue GI codes — 5 insights
USPI delivers $502M operating revenue in Q3, Tenet’s hospital operations disappoint

Advertisement

Next Up in GI & Endoscopy

Advertisement

Comments are closed.